Concepedia

Multiple-pool cell lifespan models for neutropenia to assess the population pharmacodynamics of unbound paclitaxel from two formulations in cancer patients

Jürgen B. Bulitta, Ping Zhao, Robert D. Arnold, Dean R. Kessler, Richard Daifuku, James Pratt, Gabriel Luciano, Axel‐R. Hanauske, Hans Gelderblom, Ahmad Awada,

Cancer Chemotherapy and Pharmacology · 2008 · 26 citations · 37 references

DOI

Concepts

References

37

Handbook of Physiology.

F. Plum · Archives of Neurology · 1960 · 10.4K citations

, , +10

Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins

Alfred H. Schinkel, Ulrich Mayer, Els Wagenaar et al. · Proceedings of the National Academy of Sciences · 1997 · 941 citations

, , +11

Clinical toxicities encountered with paclitaxel (Taxol).

Rowinsky Ek, Eisenhauer Ea, Arbuck Sg et al. · PubMed · 1993 · 698 citations

, , +12

European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion.

Elizabeth A. Eisenhauer, W.W. ten Bokkel Huinink, Kenneth D. Swenerton et al. · Journal of Clinical Oncology · 1994 · 641 citations

, , +16

Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans.

Luca Gianni, Christine M. Kearns, Antonio Giani et al. · Journal of Clinical Oncology · 1995 · 562 citations

, , +15